TAF1 INHIBITORS

Disclosed are inhibitors for TAF1. The TAF1 inhibitors are compounds having a structure according to one of the Formula described herein. Methods of using the disclosed compounds to treat proliferative disorders are also disclosed. L'invention concerne des inhibiteurs de TAF1. Les inhibiteurs d...

Full description

Saved in:
Bibliographic Details
Main Authors SHULTZ, Zachary, LOPCHUK, Justin, SCHONBRUNN, Ernst, KARIM, Md Rezaul
Format Patent
LanguageEnglish
French
Published 23.09.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Disclosed are inhibitors for TAF1. The TAF1 inhibitors are compounds having a structure according to one of the Formula described herein. Methods of using the disclosed compounds to treat proliferative disorders are also disclosed. L'invention concerne des inhibiteurs de TAF1. Les inhibiteurs de TAF1 sont des composés ayant une structure selon l'une des formules décrites dans la description. L'invention concerne également des procédés d'utilisation des composés de l'invention pour traiter des troubles prolifératifs.
Bibliography:Application Number: WO2021US23419